BLFS - BioLife Solutions, Inc.
NEXT EARNINGS:
Feb 26, 2026
(in 1 day)
EPS Est: $-0.02
|
Rev Est: $24.0M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$33.00
DETAILS
HIGH:
$34.00
LOW:
$32.00
MEDIAN:
$33.00
CONSENSUS:
$33.00
UPSIDE:
45.70%
Market Cap:
1.09B
Volume:
314,729
Avg Volume:
335,050
52 Week Range:
19.1-29.62
Sector:
Healthcare
Industry:
Medical - Instruments & Supplies
Beta:
1.92
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
159
IPO Date:
1989-11-22
EPS (TTM):
-0.44
P/E Ratio:
-59.25
Revenue (TTM):
82.25M
Total Assets:
399.49M
Total Debt:
30.17M
Cash & Equiv:
95.39M
Rev Growth (5Y):
24.6%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
57.4%
ROCE:
-1.9%
Debt/Equity:
0.09
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-08-07 | $-0.33 | $-0.02 | -1556.7% | $25.4M | $25.7M | -1.0% |
| 2025-05-08 | $0.04 | $-0.03 | +233.3% | $23.9M | $22.2M | +7.7% |
| 2025-03-03 | $-0.01 | $-0.06 | +83.3% | $3.4M | $21.8M | -84.3% |
| 2024-11-12 | $-0.02 | $-0.09 | +77.8% | $30.6M | $22.8M | +34.2% |
| 2024-08-08 | $-0.06 | $-0.14 | +57.1% | $28.3M | $23.9M | +18.3% |
| 2024-05-09 | $-0.19 | $-0.26 | +26.9% | $31.7M | $26.0M | +22.0% |
| 2024-02-29 | $-0.30 | $-0.36 | +16.7% | $32.7M | $33.4M | -2.0% |
| 2023-11-09 | $-0.67 | $-0.38 | -76.3% | $33.3M | $33.8M | -1.5% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 82.25M | 143.27M | 76.24M | 119.16M | 48.09M | 27.37M | 19.74M | 11.02M | 8.23M | 6.45M | 6.19M | 8.95M |
| Net Income | (20.18M) | (66.43M) | (139.81M) | (8.91M) | 2.67M | (1.66M) | 3.27M | (2.52M) | (6.88M) | (4.21M) | (3.22M) | (1.08M) |
| EPS | -0.44 | -1.52 | -3.29 | -0.23 | 0.07 | -0.09 | -1.56 | -0.21 | -0.54 | -0.35 | -0.31 | -0.22 |
| Total Assets | 399.49M | 412.71M | 450.23M | 552.60M | 234.83M | 93.01M | 45.47M | 12.14M | 7.93M | 12.37M | 16.07M | 3.35M |
| Total Debt | 30.17M | 33.83M | 43.71M | 26.88M | 11.15M | 1.35M | 0 | 0 | 2.84M | 0 | 0 | 10.60M |
| Cash & Equivalents | 95.39M | 27.90M | 19.44M | 69.87M | 90.46M | 6.45M | 30.66M | 6.66M | 1.41M | 3.82M | 9.94M | 156,273 |
| Operating Cash Flow | 8.43M | (12.50M) | (8.49M) | (4.84M) | 6.51M | 1.21M | 2.35M | 605,000 | (4.33M) | (4.97M) | (3.16M) | 146,007 |
| Free Cash Flow | 5.20M | (18.88M) | (18.87M) | (13.22M) | 1.88M | 538,000 | 1.85M | 461,233 | (5.58M) | (6.39M) | (3.75M) | (90,663) |
| FCF per Share | 0.11 | -0.43 | -0.44 | -0.34 | 0.07 | 0.03 | 0.11 | 0.03 | -0.44 | -0.52 | -0.36 | -0.02 |
| Book Value | 348.91M | 337.66M | 364.19M | 480.75M | 205.25M | 83.03M | 43.15M | 10.09M | 3.17M | 8.51M | 13.94M | (13.27M) |
| Cash & ST Investments | 104.58M | 44.18M | 62.70M | 69.87M | 90.46M | 6.45M | 30.66M | 6.66M | 1.41M | 3.82M | 9.94M | 156,273 |
| ROC Equity | -0.06 | -0.20 | -0.38 | -0.02 | 0.01 | -0.02 | 0.08 | -0.25 | -2.17 | -0.50 | -0.23 | N/A |